These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28273896)

  • 1. Functional conservation and coherence of HIV-1 subtype A Vpu alleles.
    Romani B; Kavyanifard A; Allahbakhshi E
    Sci Rep; 2017 Dec; 7(1):87. PubMed ID: 28273896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional conservation and coherence of HIV-1 subtype A Vpu alleles.
    Romani B; Kavyanifard A; Allahbakhshi E
    Sci Rep; 2017 Mar; 7():44894. PubMed ID: 28317943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes.
    Umviligihozo G; Cobarrubias KD; Chandrarathna S; Jin SW; Reddy N; Byakwaga H; Muzoora C; Bwana MB; Lee GQ; Hunt PW; Martin JN; Brumme CJ; Bangsberg DR; Karita E; Allen S; Hunter E; Ndung'u T; Brumme ZL; Brockman MA
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and phenotypic analyses of sequential vpu alleles from HIV-infected IFN-treated patients.
    Vanwalscappel B; Rato S; Perez-Olmeda M; Díez Fuertes F; Casartelli N; Alcami J; Mammano F
    Virology; 2017 Jan; 500():247-258. PubMed ID: 27855354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.
    Vigan R; Neil SJ
    J Virol; 2010 Dec; 84(24):12958-70. PubMed ID: 20926557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin.
    Song YE; Cyburt D; Lucas TM; Gregory DA; Lyddon TD; Johnson MC
    Viruses; 2018 Oct; 10(10):. PubMed ID: 30347660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles.
    Galaski J; Ahmad F; Tibroni N; Pujol FM; Müller B; Schmidt RE; Fackler OT
    J Acquir Immune Defic Syndr; 2016 May; 72(1):1-10. PubMed ID: 26656785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.
    Lv M; Wang J; Wang X; Zuo T; Zhu Y; Kong W; Yu X
    PLoS One; 2011; 6(6):e20890. PubMed ID: 21674066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
    Sauter D; Hué S; Petit SJ; Plantier JC; Towers GJ; Kirchhoff F; Gupta RK
    Retrovirology; 2011 Dec; 8():103. PubMed ID: 22171785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modest attenuation of HIV-1 Vpu alleles derived from elite controller plasma.
    Chen J; Tibroni N; Sauter D; Galaski J; Miura T; Alter G; Mueller B; Haller C; Walker BD; Kirchhoff F; Brumme ZL; Ueno T; Fackler OT
    PLoS One; 2015; 10(3):e0120434. PubMed ID: 25793728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vpu binds directly to tetherin and displaces it from nascent virions.
    McNatt MW; Zang T; Bieniasz PD
    PLoS Pathog; 2013; 9(4):e1003299. PubMed ID: 23633949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals.
    Pickering S; Hué S; Kim EY; Reddy S; Wolinsky SM; Neil SJ
    PLoS Pathog; 2014 Jan; 10(1):e1003895. PubMed ID: 24465210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of HIV-1-host interaction: role of the Vpu accessory protein.
    Dubé M; Bego MG; Paquay C; Cohen ÉA
    Retrovirology; 2010 Dec; 7():114. PubMed ID: 21176220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Vpu Mediates HLA-C Downregulation.
    Apps R; Del Prete GQ; Chatterjee P; Lara A; Brumme ZL; Brockman MA; Neil S; Pickering S; Schneider DK; Piechocka-Trocha A; Walker BD; Thomas R; Shaw GM; Hahn BH; Keele BF; Lifson JD; Carrington M
    Cell Host Microbe; 2016 May; 19(5):686-95. PubMed ID: 27173934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of adaptation to human tetherin in HIV-1 group O and P.
    Yang SJ; Lopez LA; Exline CM; Haworth KG; Cannon PM
    Retrovirology; 2011 Sep; 8():78. PubMed ID: 21955466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The viral protein U (Vpu)-interacting host protein ATP6V0C down-regulates cell-surface expression of tetherin and thereby contributes to HIV-1 release.
    Waheed AA; Swiderski M; Khan A; Gitzen A; Majadly A; Freed EO
    J Biol Chem; 2020 May; 295(21):7327-7340. PubMed ID: 32291285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-TrCP dependency of HIV-1 Vpu-induced downregulation of CD4 and BST-2/tetherin.
    Blanchet FP; Mitchell JP; Piguet V
    Curr HIV Res; 2012 Jun; 10(4):307-14. PubMed ID: 22524179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2.
    Hopfensperger K; Richard J; Stürzel CM; Bibollet-Ruche F; Apps R; Leoz M; Plantier JC; Hahn BH; Finzi A; Kirchhoff F; Sauter D
    mBio; 2020 Jul; 11(4):. PubMed ID: 32665270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions.
    Yoshida T; Koyanagi Y; Strebel K
    J Virol; 2013 Dec; 87(24):13825-36. PubMed ID: 24109238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin.
    Petit SJ; Blondeau C; Towers GJ
    J Gen Virol; 2011 Dec; 92(Pt 12):2937-2948. PubMed ID: 21900423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.